Videos
Increasing Utilization of Deep Brain Stimulation in Clinical Practice: Fiona Gupta, MD
June 12th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center shed some light on the use of DBS in the clinic and how it has evolved as a therapeutic option for patients with Parkinson disease. [WATCH TIME: 2 minutes]
BTK Inhibitors in the Management of Relapse and Progressive MS: Amit Bar-Or, MD, FRCPC, FAAN, FANA
June 11th 2023At CMSC 2023, the Melissa and Paul Anderson President’s Distinguished Professor of Neurology at the Perelman School of Medicine of the University of Pennsylvania, talked about the phase 2 trials that show promising results for BTK inhibitors as a potential MS therapy. [WATCH TIME: 4 minutes]
Care Access Challenges in Parkinson Disease and Movement Disorders: Fiona Gupta, MD
June 10th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center spoke about the challenges with access to care in movement disorders. [WATCH TIME: 2 minutes]
The Expansion of Botulinumtoxin in the Clinical Care of Parkinson Disease: Laxman Bahroo, DO
June 10th 2023The professor of neurology and residency program director at MedStar Georgetown University Hospital discussed the value of educating clinicians on the utility of botulinumtoxins in PD care. [WATCH TIME: 3 minutes]
Ensuring Good Quality of Life With Good ON Time in Parkinson Disease: Khash Dashtipour, MD, PhD
June 9th 2023The director of the Movement Disorders Division at Loma Linda University discussed the importance of understanding good ON time in Parkinson disease care, and how it can influence quality of life. [WATCH TIME: 5 minutes]
The Impact of Social and Environmental Determinants, Race on Sleep: Dayna Johnson, PhD, MPH, MSW, MS
June 9th 2023The sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University, insight on the associations between race, socioeconomic backgrounds, and poor sleep and insufficient sleep. [WATCH TIME: 2 minutes]
Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis - Recent Updates
June 9th 2023In this episode of MEDcast, expert neurologists delve into anti-CD20 disease modifying therapies (DMTs) in MS. They assess the correlation between clinical observations and immunological processes in MS patients, and also examine the role of the Epstein Barr virus in MS.
Diagnosis and Preventive Treatment Approaches in Managing NMOSD: Brian G. Weinshenker, MD, FRCP
June 8th 2023The professor of neurology at the University of Virginia discussed the progress made in recognizing and diagnosing neuromyelitis optica spectrum disorder through the discovery of specific monoclonal antibodies. [WATCH TIME: 5 minutes]
Critical Updates to the Treatment of Restless Legs Syndrome: John Winkelman, MD, PhD
June 7th 2023The chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital provided insight on new updates to the management of restless legs syndrome, including removing dopamine agonists as first line treatments. [WATCH TIME: 8 minutes]
Complexities With Management of Insomnia in Children and Adolescents: Judith Owens, MD
June 5th 2023The professor of neurology in the Division of Sleep Medicine at Harvard Medical School provided insight on current management of insomnia for children and adolescents, and where improvements could be made. [WATCH TIME: 3 minutes]
New Insights on Discovering Targeted Therapies for Progressive MS: Anne H. Cross, MD
June 4th 2023The professor of neurology at Washington University School of Medicine discussed progressive multiple sclerosis and the need for targeted therapies to address the progression and associated challenges. [WATCH TIME: 5 minutes]
Challenges and Advancements in Biomarkers for Accurate Diagnosis in MS: Andrew Solomon, MD
June 3rd 2023At CMSC 2023, the associate professor of neurological sciences at the University of Vermont in Burlington talked about data surrounding multiple sclerosis diagnosis and misdiagnosis, suggesting the need for the development of diagnostic biomarkers. [WATCH TIME: 5 minutes]
Building and Expanding Wearable Devices to Alleviate MS Symptoms: Valerie J. Block, PT, DPTSc
June 2nd 2023The adjunct instructor at the UCSF Weill Institute for Neurosciences provided perspective on the next steps in research for potential wearable devices focused on treating issues of multiple sclerosis. [WATCH TIME: 2 minutes]
Role of Cholinergic Transcripts in Sex-Specific Declines of Alzheimer Disease: Hermona Seroq, PhD
June 1st 2023The professor of molecular neuroscience at the Edmond and Lily Safra Center for Brain Sciences discussed the premise behind a study of RNA-sequencing data to better understand the reasons why females suffer accelerated dementia. [WATCH TIME: 9 minutes]
